TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer Associated With Homologous Recombination Deficiency

What is the purpose of this trial?

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib.

Participation Guidelines

Ages: 18 years and older

Gender: Male only

Clovis Oncology, Inc.

Dates: 11/17/2017 - 10/31/2019

Last Updated: 11/30/2017

Study HIC#: 2000020433